In the BioHarmony Drug Report Database

"Preview" Icon

Eprosartan

Teveten (eprosartan) is a small molecule pharmaceutical. Eprosartan was first approved as Teveten on 1997-12-22. It is used to treat diabetic nephropathies, heart failure, hypertension, and left ventricular dysfunction in the USA. The pharmaceutical is active against type-1 angiotensin II receptor.

 

Trade Name

 

Teveten
 

Common Name

 

eprosartan
 

ChEMBL ID

 

CHEMBL813
 

Indication

 

diabetic nephropathies, heart failure, hypertension, left ventricular dysfunction
 

Drug Class

 

Angiotensin II receptor antagonists

Image (chem structure or protein)

Eprosartan structure rendering